These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 6975166)

  • 1. Reversal of methotrexate toxicity in mice by a calcium salt of citrovorum factor and related compounds.
    Temple C; Rose JD; Laster WR; Montgomery JA
    Cancer Treat Rep; 1981; 65(11-12):1117-9. PubMed ID: 6975166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aspects of the reversal of methotrexate toxicity in rodents.
    Kisliuk RL; Tattersall MH; Gaumont Y; Pastore EJ; Brown B
    Cancer Treat Rep; 1977 Jul; 61(4):647-50. PubMed ID: 301779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversal of methotrexate toxicity in mice by 5-methyltetrahydrofolic acid.
    Blair JA; Searle CE
    Br J Cancer; 1970 Sep; 24(3):603-9. PubMed ID: 5312191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Letter: Methotrexate with citrovorum-factor rescue.
    Falk L
    N Engl J Med; 1975 Jun; 292(26):1406-7. PubMed ID: 1079571
    [No Abstract]   [Full Text] [Related]  

  • 5. [Radiational basis and practice of the citrovorum factor (Leucovorin) protection after high-dose methotrexate therapy. High-dose methotrexate/leucovorin].
    Sauer H; Schalhorn A
    Onkologie; 1980 Apr; 3(2):64-71. PubMed ID: 6994007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase I study of high-dose methotrexate with thymidine and low-dose leucovorin.
    Bruno S; Grindey G; Zakrzewski S; Priore R; Kinahan J; Moayeri H; Ledesma E; Mittelman A; Creaven P
    Cancer Res; 1982 Nov; 42(11):4824-6. PubMed ID: 6982097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of folinic acid (leucovorin) on cytotoxic and cytogenetic effects of methotrexate].
    Pieńkowska K; Koziorowska J
    Folia Med Cracov; 1986; 27(3-4):239-44. PubMed ID: 3494651
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunosuppressive effects of tandem administration of methotrexate and folinic acid.
    Morgado F; Folch H; Mena M
    Folia Biol (Praha); 1971; 17(1):18-25. PubMed ID: 5313597
    [No Abstract]   [Full Text] [Related]  

  • 9. High-dose methotrexate with citrovorum factor rescue for patients with refractory lymphoproliferative disorders.
    Case DC
    J Maine Med Assoc; 1980 Dec; 71(12):355-8. PubMed ID: 6970790
    [No Abstract]   [Full Text] [Related]  

  • 10. Methotrexate and the citrovorum factor in the treatment of psoriasis.
    Ive FA; De Saram CF
    Trans St Johns Hosp Dermatol Soc; 1970; 56(1):45-7. PubMed ID: 5312493
    [No Abstract]   [Full Text] [Related]  

  • 11. Time limitations in the reversal by citrovorum factor of methotrexate-induced immunosuppression in mice.
    Medzihradsky J; Ehrke J; Mihich E
    Biochem Pharmacol; 1977 Feb; 26(3):203-6. PubMed ID: 300243
    [No Abstract]   [Full Text] [Related]  

  • 12. Pulmonary toxicity in mice after high-dose methotrexate administration with and without leucovorin rescue.
    Pesce C; Mansi C; Bogliolo G; Tobia F; Pannacciulli I
    Eur J Cancer Clin Oncol; 1985 Jul; 21(7):875-80. PubMed ID: 3876219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leucovorin and maximum tolerated dose toxicity of methotrexate in rats.
    Fuskevåg OM; Kristiansen C; Lindal S; Aarbakke J
    Pediatr Hematol Oncol; 2000 Dec; 17(8):651-8. PubMed ID: 11127396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase I trial of paclitaxel, carboplatin, and methotrexate with granulocyte colony-stimulating factor and leucovorin in advanced transitional cell carcinoma.
    Edelman MJ; Meyers FJ; Houston J; Lauder I
    Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-68-S15-71. PubMed ID: 9346226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methotrexate.
    IARC Monogr Eval Carcinog Risk Chem Hum; 1981 May; 26():267-92. PubMed ID: 6944263
    [No Abstract]   [Full Text] [Related]  

  • 16. The reversal of methotrexate toxicity by thymidine with maintenance of antitumour effects.
    Tattersall MH; Brown B; Frei E
    Nature; 1975 Jan; 253(5488):198-200. PubMed ID: 1078601
    [No Abstract]   [Full Text] [Related]  

  • 17. Radioimmunoassays for methotrexate, citrovorum factor, neocarzinostatin, and actinomycin D.
    Raso V
    Cancer Treat Rep; 1977 Jul; 61(4):585-90. PubMed ID: 141980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assay for citrovorum factor (NSC-3590) in the presence of methotrexate (NSC-740).
    Mehta BM; Hutchison DJ
    Cancer Chemother Rep; 1975; 59(5):935-7. PubMed ID: 1081908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of single-agent chemotherapy regimens for gestational trophoblastic disease.
    Homesley HD
    J Reprod Med; 1994 Mar; 39(3):185-92. PubMed ID: 7518517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Folic acid prevention of the adverse effects of methotrexate].
    Szabó G; Mezei G
    Fogorv Sz; 1984 Mar; 77(3):71-3. PubMed ID: 6608458
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.